The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 16 , ISSUE 6 ( June, 2015 ) > List of Articles

RESEARCH ARTICLE

Alpha-2-Macroglobulin Levels in Gingival Crevicular Fluid Pre- and Post-scaling and Root Planing with Adjunctive Tetracycline Fibers in Chronic Periodontitis: A Randomized Controlled Trial

Shivjot Chhina, Ajit Singh Rathore, Saurabh Juneja

Citation Information : Chhina S, Rathore AS, Juneja S. Alpha-2-Macroglobulin Levels in Gingival Crevicular Fluid Pre- and Post-scaling and Root Planing with Adjunctive Tetracycline Fibers in Chronic Periodontitis: A Randomized Controlled Trial. J Contemp Dent Pract 2015; 16 (6):474-478.

DOI: 10.5005/jp-journals-10024-1709

Published Online: 01-06-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background

This split-mouth clinical study aimed to investigate levels of alpha-2-macroglobulin (α2M) in gingival crevicular fluid (GCF) of chronic periodontitis patients pre- and post-scaling and root planing (SRP) with or without adjunctive use of tetracycline fibers.

Materials and methods

In 30 patients of chronic periodontitis, samples of GCF were collected from the gingival sulcus before SRP. Recording of clinical parameters was conducted. This was followed by local drug delivery (LDD) of tetracycline fibers in test sites. In control sites, no LDD was done. Second samples of GCF were taken 90 days after treatment. Samples of crevicular fluid were analyzed to determine the levels of α2m.

Results

A gain of clinical attachment (CAL) of 3.30 mm for SRP and LDD and for SRP alone was 1.62 mm (p < 0.001). The pocket probing depth was significantly decreased by 2.43 mm for SRP and LDD and for SRP alone was 1.61 mm (p < 0.001) after 90 days. Alpha-2-macroglobulin was significantly reduced in GCF by SRP and SRP and LDD after 90 days (p < 0.001).

Conclusion

Clinical and biochemical variables showed a more favorable outcome when SRP was combined with LDD of tetracycline fibers in management of patients suffering from chronic periodontitis.

How to cite this article

Chhina S, Rathore AS, Juneja S. Alpha-2-Macroglobulin Levels in Gingival Crevicular Fluid Pre- and Post-scaling and Root Planing with Adjunctive Tetracycline Fibers in Chronic Periodontitis: A Randomized Controlled Trial. J Contemp Dent Pract 2015;16(6):474-478.


PDF Share
  1. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003;82:82-90.
  2. The ability of gingival crevicular fluid acute phase proteins to distinguish healthy, gingivitis and periodontitis sites. J Clin Periodontol 1992;19:98-102.
  3. Innate immunity, antimicrobial peptides, and protection of the oral cavity. Lancet 2002;360:1116-1117.
  4. Evaluation of components of gingival crevicular fluid as diagnostic tests. Ann Periodontol 1997;2:123-137.
  5. Proteases and their inhibitors in chronic inflammatory periodontal disease. J Clin Periodontol 1986;13:19-26.
  6. Human plasma proteinase inhibitors. Annu Rev Biochem 1983;52:655-709.
  7. Cathepsin B, alpha-2-macroglobulin and cystatin levels in gingival crevicular fluid from chronic periodontitis patients. J Clin Periodontol 1998;25:34-41.
  8. Interaction of alpha-2-macroglobulin with matrix metalloproteinases and its use for identification of their active forms. Ann N Y Acad Sci 1994;732:294-302.
  9. Gingival crevicular fluid levels of aspartate aminotransferase and alpha-2-macroglobulin before and after topical application of metronidazole or scaling and root planning. Quintessence Int 2008;39(5):381-389.
  10. Gingival fluid and serum in periodontal diseases I, Quantitative study of immunoglobulins, complement components, and other plasma proteins. J Periodontol 1977;48:772-777.
  11. Alpha-macroglobulins: structure, shape and mechanism of proteinase complex formation. J Biol Chem 1989;264:11539-11542.
  12. Alpha-2- macroglobulin in sulci from healthy and inflamed human gingivae. Infection and immunity 1982;36:66-71.
  13. The effect of treatment on IgG, IgA, IgM and (alpha-2- macroglobulin in gingival Crevicular fluid from patients with chronic adult periodontitis. Arch Oral Bio 1988;33:425-431.
  14. In vitro synthesis of alpha-2-macroglobulin by human gingival fibroblasts. Arch Oral Bio 1988;33:407-412.
  15. Synthesis of alpha-2-macroglobulin in human gingiva: a study of the concentration of macroglobulin and albumin in gingival fluid and serum. Arch Oral Bio 1990;35:13-16.
  16. Elevated conversion of alpha-2- macroglobulin to the complexed form in gingival crevicular fluid from adult periodontitis patients. J Periodontol 1995;30:436-444.
  17. Papers. Oak Brook, Illinois, October 30-November 2, 1999. Ann Periodontol 1999;32-37.
  18. Reduced plaque formation by the chloromethyl analogue of vitamin C. J Periodontol 1970;41:41-43.
  19. Periodontal disease in pregnancy. Acta Odontol Scand 1963;21:533-542.
  20. Gingival sulcus bleeding: a leading symptom in initial gingivitis. Helev Odontol Acta 1971;15:107-113.
  21. Effect of nonsurgical periodontal therapy (VIII). Probing attachment changes related to clinical characteristics. J Clin Periodontol 1987;14:425-432.
  22. Debridement and local application of tetracycline-loaded fibres in the management of persistent periodontitis: results after 12 months. J Clin Periodontol 2004;31:166-172.
  23. Comparison of 3 periodontal local antibiotic therapies in persistent periodontal pockets. J Periodontol 1996;67:860-865.
  24. Bacterial invasion of gingiva in advanced periodontitis in humans. J Periodontol 1982;53:217-222.
  25. Effects of topical metronidazole and tetracycline in treatment of adult periodontitis. J Periodontol 1998;69:819-827.
  26. A 4-quadrant comparative study of periodontal treatment using tetracycline containing drug delivery fibers and scaling. J Clin Periodontol 1991;18:111-116.
  27. Tetracyclines in the management of periodontal diseases: a review. J Clin Periodontol 1995;22:22-35.
  28. A new degradable controlled release device for treatment of periodontal disease: in vitro release study. J Periodontol 1990;61:393-398.
  29. The adjunctive use of locally delivered tetracyclines in periodontal therapy: a narrative review of the recent literature. Int Dent Med J Adv Res 2015;1:1-4.
  30. Elastase, alpha-2-macroglobulin and alkaline phosphatase in crevicular fluid from implants with and without periimplantitits. Clin Oral Implants Res 2002;13:227-233.
  31. Analyse von alpha- 2-macroglobulin in gesunder gingiva und bei parodontitis. Dtsch Zahnärztl Z 2000;55:497-501.
  32. Risk factors associated with periodontal diseases and their clinical considerations. Int J Contemp Dent Med Rev 2015;2015: Article ID: 040115. doi : 10.15713/ins.ijcdmr.31
  33. ‘Pharmacological agents for periodontal regeneration: a review.’ Int J Contemp Dent Med Rev 2015; 2015: Article ID: 120115. doi : 10.15713/ ins.ijcdmr.35.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.